Clean allergen profile with a fragrance free formula.

Retinal (retinaldehyde) is the most potent cosmetic vitamin A ingredient available without a prescription and is within accepted safety limits at 0.1% for cosmetic use. Like all vitamin A ingredients, it should not be used during pregnancy and should not be combined with other vitamin A products. One ingredient is listed as 'Ester of Ethyl Olivate', which is not the recognised standard ingredient name. The correct name is 'Ethyl Olivate', an olive-derived emollient. Without the standard name, a complete public safety assessment for that ingredient requires trust in the brand rather than independent verification. No synthetic fragrance, no parabens.

Retinal is a more advanced vitamin A form than retinol. Retinol requires two conversion steps inside the skin before becoming active; retinal requires only one, delivering faster, stronger results at the same concentration. The rich emollient base of squalane, medium-chain triglycerides, and other oils is designed to offset the dryness and peeling that comes with starting a retinoid. Niacinamide is a deliberate and clinically supported formulation choice to reduce the barrier disruption and inflammation that retinal triggers, especially during the initial tolerance-building period. Tinogard TT is a specialist antioxidant added specifically to protect the retinal from breaking down before use.

The brand discloses 0.1% retinal concentration clearly on label, which is a meaningful transparency step that most retinoid brands skip. The retinal versus retinol distinction is correctly communicated. One INCI naming issue with 'Ester of Ethyl Olivate' remains. Niacinamide and peptide concentrations are not disclosed. No independent clinical studies for this formula have been published.

No independent clinical study or safety assessment is publicly accessible for this formula. The disclosed 0.1% retinal concentration is a positive transparency step above the industry baseline. No efficacy data such as wrinkle reduction measurements or tolerability outcomes have been published.

The retinal versus retinol distinction is clearly explained and concentration is disclosed. Night-use-only and SPF-next-morning guidance is communicated. The 'Ester of Ethyl Olivate' naming non-compliance is a minor consumer clarity gap. Pregnancy and stacking contraindications should be more prominently communicated.